Dianthus Therapeutics, Inc.

NASDAQ:DNTH

Biotechnology

Healthcare
$84.83 -1.25%

-$1.03 today

Market cap
$4.78B
Beta
0.07
P/E (TTM)
-343.0
EPS (TTM)
-$0.24
52W Low $16.64High $96.50

Volume 0.89M

Average 0.82M

Balance Sheet

Inspect the capital base behind the business.

Assets

$530.92M

FY 2025 · Annual

+42.0% YoY

Liabilities

$37.52M

FY 2025 · Annual

+74.3% YoY

Equity

$493.40M

FY 2025 · Annual

+40.0% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents131.65M15.37M132.33M22.79M51.09M
Short-term Investments45.28M60.13M41.39M252.45M353.21M
Net Receivables05.64M478K807K102K
Inventory00000
Other Current Assets3.77M53K504K355K5.04M
Total Current Assets180.69M82.03M177.45M280.9M409.44M
Property, Plant & Equipment (Net)7.46M956K800K1.75M1.63M
Goodwill00000
Intangible Assets00000
Long-term Investments1.78M0081.73M110.14M
Tax Assets00000
Other Non-current Assets0121K1.15M9.63M9.72M
Total Non-current Assets9.24M1.08M1.95M93.1M121.48M
Total Assets189.93M83.11M179.41M374.01M530.92M
Account Payables3.04M1.17M2.61M4.58M9.73M
Short-term Debt00000
Tax Payables00000
Deferred Revenue0100K100K479K1.19M
Other Current Liabilities4.48M2.08M5.36M5.15M9.52M
Total Current Liabilities10.86M8.23M9.63M18.45M30.73M
Long-term Debt00001.02M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)0791K736K1.91M5.77M
Other Non-current Liabilities6.4M0000
Total Non-current Liabilities6.4M1.23M904K3.08M6.79M
Total Liabilities17.26M9.45M10.54M21.53M37.52M
Common Stock59K015K31K43K
Retained Earnings(325.57M)(45.87M)(89.42M)(174.39M)(336.73M)
Accumulated OCI(30K)(161K)47K106K489K
Other Stockholders Equity00000
Minority Interest00000
Total Equity172.67M73.66M168.87M352.48M493.4M
Total Debt0788K585K1.49M1.39M
Net Debt(131.65M)(14.58M)(131.74M)(21.3M)(49.7M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$110.5M
Short-term Investments$776.3M
Receivables$106.0K
Other Current$10.6M
Total Current Assets$897.5M
PP&E (Net)$1.6M
Long-term Investments$303.6M
Other Non-current$10.5M
Total Non-current Assets$315.7M
Total Assets$1.2B

Analysis

Selected assets total $1.2B for Latest. The largest visible component is Short-term Investments at $776.3M, about 64.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 12, 2026
8-KCurrent reportNov 4, 2026
10-QQuarterly reportNov 4, 2026
SC 13GSC 13G filingOct 30, 2026
4Statement of changes in beneficial ownershipSep 18, 2026

How much cash does DNTH have?

Dianthus Therapeutics, Inc. (DNTH) reported $51.09M in cash and equivalents in fiscal 2025.

How much debt does DNTH carry?

Dianthus Therapeutics, Inc. (DNTH) reported $1.39M of total debt, with net debt of -$49.70M.